WP1130 10mg
10mg
| Purity Not Available
Adooq Bioscience
WP1130 (Degrasyn) is a novel selective small molecular deubiquitinase inhibitor and a Bcr/Abl destruction pathway activator that specifically and rapidly down-regulates both wild-type and mutant Bcr/Abl protein without affecting bcr/abl gene expression in chronic myelogenous leukemia (CML) cells.
More Information
Supplier Page
VX-809 50mg
50mg
| Purity Not Available
Adooq Bioscience
VX-809 5mg
5mg
| Purity Not Available
Adooq Bioscience
WYE-354 25mg
25mg
| Purity Not Available
Adooq Bioscience
WYE-354 is a potent cell-permeable inhibitor of mTOR (IC50 = 4.3 nM) which blocks signaling through both mTOR complex 1 (mTORC1) and mTORC2. It is a much weaker inhibitor of PI3K ?? (IC50 = 1026 nM) and other kinases.
More Information
Supplier Page
WYE-354 5mg
5mg
| Purity Not Available
Adooq Bioscience
WYE-354 is a potent cell-permeable inhibitor of mTOR (IC50 = 4.3 nM) which blocks signaling through both mTOR complex 1 (mTORC1) and mTORC2. It is a much weaker inhibitor of PI3K ?? (IC50 = 1026 nM) and other kinases.
More Information
Supplier Page
Adooq Bioscience
WZ4002 is EGFR inhibitor against EGFR T790M (mutation of the gatekeeper T790 residue) which is detected in 50% of clinically resistant patients to gefitinib or erlotinib.
More Information
Supplier Page
WZ4002 100mg
100mg
| Purity Not Available
Adooq Bioscience
WZ4002 is EGFR inhibitor against EGFR T790M (mutation of the gatekeeper T790 residue) which is detected in 50% of clinically resistant patients to gefitinib or erlotinib.
More Information
Supplier Page
WZ4002 10mg
10mg
| Purity Not Available
Adooq Bioscience
WZ4002 is EGFR inhibitor against EGFR T790M (mutation of the gatekeeper T790 residue) which is detected in 50% of clinically resistant patients to gefitinib or erlotinib.
More Information
Supplier Page
WZ3146 50mg
50mg
| Purity Not Available
Adooq Bioscience
WZ3146 is an inhibitor of EGFR receptor kinase mutants carrying a mutation in an active site gatekeeper residue (T790M) and is much less potent against wild-type EGFR kinase.
More Information
Supplier Page
WZ3146 5mg
5mg
| Purity Not Available
Adooq Bioscience
WZ3146 is an inhibitor of EGFR receptor kinase mutants carrying a mutation in an active site gatekeeper residue (T790M) and is much less potent against wild-type EGFR kinase.
More Information
Supplier Page